It is our expectation that by focusing on the specific embryonic mechanisms of GRP78 utilized by cancer, this will reveal the specific GRP78-mediated mechanisms that lead to the most aggressive cancer outcomes, and that this information will be critical in focusing future therapeutic targeting of sGRP78 in a clinical setting. This evidence concerns the gene HSPA5 and cancer.